Vincent Woo
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Surgery top 2%
- Pancreatic function and diabetes
Papers in
-
- Diabetes Treatment and Management 76
- Diabetes Management and Research 59
- Hyperglycemia and glycemic control in critically ill and hospitalized patients 14
- Diabetes, Cardiovascular Risks, and Lipoproteins 6
- Surgery 39
- Pancreatic function and diabetes 38
- Co-authors
- James F. ListWeihua TangEnrique MoralesFred T. FiedorekBernard ZinmanBruce W. BodeLori BerardStephen Gough
- Journals
- Canadian Journal of Diabetes (31 papers)Diabetes Obesity and Metabolism (14 papers)Diabetes Care (6 papers)International Journal of Clinical Practice (3 papers)Diabetes Therapy (3 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Vincent Woo
91 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Endocrinology, Diabetes and Metabolism 4.0k
- Surgery 1.6k
- Pharmacology 614
- Nephrology 173
- Molecular Biology 1.6k
Countries citing papers authored by Vincent Woo
This map shows the geographic impact of Vincent Woo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Woo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Woo more than expected).
Fields of papers citing papers by Vincent Woo
This network shows the impact of papers produced by Vincent Woo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Woo. The network helps show where Vincent Woo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Vincent Woo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 16 | |
| 3 | 2021 | 12 | |
| 4 | 2020 | 20 | |
| 5 | 2019 | 12 | |
| 6 | Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial Hit paper breakdown → | 2019 | 267 |
| 7 | 2018 | 9 | |
| 8 | 2018 | 3 | |
| 9 | 2018 | 4 | |
| 10 | 2017 | 10 | |
| 11 | 2016 | 35 | |
| 12 | 2015 | 8 | |
| 13 | 2015 | 17 | |
| 14 | 2014 | 3 | |
| 15 | 2013 | 1 | |
| 16 | Long-Term Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Receiving High Doses of Insulin | 2012 | 25 |
| 17 | 2009 | 4 | |
| 18 | 2008 | 11 | |
| 19 | Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes Hit paper breakdown → | 2008 | 569 |
| 20 | 2008 | 26 |
About Vincent Woo
Vincent Woo is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Pharmacology, Family Practice and Genetics, having authored 93 papers that have together received 4.5k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (76 papers), Diabetes Management and Research (59 papers), Pancreatic function and diabetes (38 papers), Metabolism, Diabetes, and Cancer (28 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (14 papers), Diabetes and associated disorders (12 papers), Pharmacology and Obesity Treatment (9 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.0k citations), Surgery (1.6k citations), Pharmacology (614 citations), Nephrology (173 citations) and Molecular Biology (1.6k citations). Vincent Woo has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include James F. List, Weihua Tang, Enrique Morales, Fred T. Fiedorek, Bernard Zinman, Bruce W. Bode, Lori Berard, Stephen Gough, Jean‐François Yale and Ronald Goldenberg. Their work appears in journals such as Canadian Journal of Diabetes, Diabetes Obesity and Metabolism, Diabetes Care, International Journal of Clinical Practice and Diabetes Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.